Vanessa Contreras
Overview
Explore the profile of Vanessa Contreras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Woodworth J, Contreras V, Christensen D, Naninck T, Kahlaoui N, Gallouet A, et al.
Nat Commun
. 2024 Oct;
15(1):8959.
PMID: 39420177
Development of new vaccines tailored for difficult-to-target diseases is hampered by a lack of diverse adjuvants for human use, and none of the currently available adjuvants induce Th17 cells. Here,...
2.
Paulet E, Contreras V, Galhaut M, Rosenkrands I, Holland M, Burton M, et al.
PLoS Negl Trop Dis
. 2024 Aug;
18(8):e0012388.
PMID: 39093884
Background: Trachoma is a leading cause of infection-related blindness worldwide. This disease is caused by recurrent Chlamydia trachomatis (Ct) infections of the conjunctiva and develops in two phases: i) active...
3.
Galhaut M, Lundberg U, Marlin R, Schlegl R, Seidel S, Bartuschka U, et al.
Commun Med (Lond)
. 2024 Apr;
4(1):62.
PMID: 38570605
Background: The fight against COVID-19 requires mass vaccination strategies, and vaccines inducing durable cross-protective responses are still needed. Inactivated vaccines have proven lasting efficacy against many pathogens and good safety...
4.
Huot N, Planchais C, Rosenbaum P, Contreras V, Jacquelin B, Petitdemange C, et al.
Nat Immunol
. 2023 Nov;
24(12):2068-2079.
PMID: 37919524
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA generally becomes undetectable in upper airways after a few days or weeks postinfection. Here we used a model of viral infection in...
5.
Fenwick C, Turelli P, Duhoo Y, Lau K, Herate C, Marlin R, et al.
J Infect
. 2023 Oct;
87(6):524-537.
PMID: 37852477
Objectives: Due to the rapid evolution of SARS-CoV-2 to variants with reduced sensitivity to vaccine-induced humoral immunity and the near complete loss of protective efficacy of licensed therapeutic monoclonal antibodies,...
6.
Marc A, Marlin R, Donati F, Prague M, Kerioui M, Herate C, et al.
PLoS Comput Biol
. 2023 Aug;
19(8):e1010721.
PMID: 37556476
The impact of variants of concern (VoC) on SARS-CoV-2 viral dynamics remains poorly understood and essentially relies on observational studies subject to various sorts of biases. In contrast, experimental models...
7.
Woodworth J, Contreras V, Christensen D, Naninck T, Kahlaoui N, Gallouet A, et al.
bioRxiv
. 2023 Mar;
PMID: 36865310
After clean drinking water, vaccination is the most impactful global health intervention. However, development of new vaccines against difficult-to-target diseases is hampered by the lack of diverse adjuvants for human...
8.
Lorenzen E, Contreras V, Olsen A, Andersen P, Desjardins D, Rosenkrands I, et al.
Front Immunol
. 2022 Dec;
13:1057375.
PMID: 36505459
It is of international priority to develop a vaccine against sexually transmitted infections to combat the continued global spread of the infection. The optimal immunization strategy still remains to be...
9.
Marlin R, Desjardins D, Contreras V, Lingas G, Solas C, Roques P, et al.
Nat Commun
. 2022 Aug;
13(1):5108.
PMID: 36042198
The COVID-19 pandemic has exemplified that rigorous evaluation in large animal models is key for translation from promising in vitro results to successful clinical implementation. Among the drugs that have...
10.
Rascle P, Planchais C, Jacquelin B, Lazzerini M, Contreras V, Passaes C, et al.
Commun Biol
. 2022 Jul;
5(1):674.
PMID: 35798936
HIV infection induces tissue damage including lymph node (LN) fibrosis and intestinal epithelial barrier disruption leading to bacterial translocation and systemic inflammation. Natural hosts of SIV, such as African Green...